Deutsch English Français

Contact

EP1530582

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1530582

EP1530582 - DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 20.03.2009 Database last updated on 03.10.2024
Most recent event Tooltip	20.03.2009	Application deemed to be withdrawn	published on 22.04.2009 [2009/17]
Applicant(s)	For all designated states OHIO UNIVERSITY Technology Transfer Office Unit 14, 340 West State Street Athens, Ohio 45701 / US
	[N/P]
Former [2005/20]	For all designated states Ohio University Technology Transfer Office, Unit 14, 340 West State Street Athens, Ohio 45701 / US
Inventor(s)	01 / KOPCHICK, John, J. 4 Orchard Lane Athens, OH 45701 / US
	02 / COSCHIGANO, Karen, T. 11703 Channingway Blvd. The Plains, OH 45780 / US
	03 / WETZEL, Amy, N. 7365 Palmleaf Lane Columbus, OH 43235-4210 / US
	[2007/10]
Former [2005/20]	01 / KOPCHICK, John, J. 4 Orchard Lane Athens, OH 45701 / US
	02 / COSCHIGANO, Karen, T. 11703 Channingway Blvd. The Plains, OH 45780 / US
	03 / HOLLAND, Amy, N. 2518 Cleveland Road Wooster, OH 44691 / US
Representative(s)	Høiberg P/S Adelgade 12 1304 Copenhagen K / DK
	[N/P]
Former [2005/20]	HOEIBERG A/S European Patent & Trademark Attorneys Store Kongensgade 59A 1264 Copenhagen K / DK
Application number, filing date	03767048.6	04.08.2003
	[2005/20]
	WO2003US24053
Priority number, date	US20020400052P	02.08.2002 Original published format: US 400052 P
	[2005/20]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2004013289
	Date:	12.02.2004
	Language:	EN
	[2004/07]
	Type:	A2 Application without search report
	No.:	EP1530582
	Date:	18.05.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.02.2004 takes the place of the publication of the European patent application.
	[2005/20]
Search report(s)	International search report - published on:	US	03.02.2005
	(Supplementary) European search report - dispatched on:	EP	21.07.2008
Classification	IPC:	C07H21/04, C07K17/00, C12Q1/00, C12N15/63, A61K38/00, A61K48/00, A61K38/17, A61P13/12	[2008/33]
	CPC:	A01K67/0275 (EP,US); A61K38/177 (EP,US); A61K38/465 (EP,US); A61K38/53 (EP,US); A61P13/12 (EP); C07K14/47 (EP,US); (+) A01K2217/05 (EP,US); A01K2227/105 (EP,US); A01K2267/03 (EP,US); A61K38/00 (EP,US); G01N2800/347 (EP,US) (-)
	Former IPC [2005/20]	C07H21/04, C07K17/00, C12Q1/00, C12N15/63, A61K38/00, A61K48/00
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/20]
Title	German:	DIAGNOSE VON NIERENSCHADEN UND PREVENTION DAGEGEN	[2005/20]
	English:	DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME	[2005/20]
	French:	DIAGNOSTIC DES LESIONS RENALES ET PREVENTION DE CES DERNIERES	[2005/20]
Entry into regional phase	02.03.2005	National basic fee paid
	02.03.2005	Search fee paid
	03.08.2005	Designation fee(s) paid
	03.08.2005	Examination fee paid
Examination procedure	29.04.2005	Amendment by applicant (claims and/or description)
	03.08.2005	Examination requested [2005/39]
	18.10.2008	Application deemed to be withdrawn, date of legal effect [2009/17]
	04.12.2008	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/17]
Fees paid	Renewal fee
	31.08.2005	Renewal fee patent year 03
	31.08.2006	Renewal fee patent year 04
	31.08.2007	Renewal fee patent year 05
	08.08.2008	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO9518225 (MEDICAL RES COUNCIL [GB], et al) [Y] 1,4,6-10 * page 11, lines 17-32 * * page 9, lines 4-15 * * page 8 * * page 7, lines 23-35 * * page 1, lines 1-5 * * abstract *;
		[Y]US5654170 (KLINGER KATHERINE W [US], et al) [Y] 1,4,6-10 * column 11, lines 38-40 * * column 10, lines 10-67 * * column 7, lines 18-20 * * column 6, lines 40-55 * * column 2, lines 33-48 * * column 1, lines 4-7 * * abstract *;
		[Y]EP0825260 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1,4,6-10 * page 12 - page 22 * * page 10, lines 22-25 * * page 9, lines 18-22,42-44 * * page 7, lines 49-52 * * page 4, lines 6-15,53-55 * * page 3, lines 1-5 * * page 2, lines 54-57 * * abstract *;
		[Y] - ZHANG H ET AL, "Screening for genes up-regulated in 5/6 nephrectomized mouse kidney.", KIDNEY INTERNATIONAL, (1999), vol. 56, pages 549 - 558, XP002486991 [Y] 1,4,6-10 * page 557, column 2 * * page 555, column 2 * * page 552, column 3 * * abstract * DOI: http://dx.doi.org/10.1046/j.1523-1755.1999.00561.x
		[Y] - CEBRIAN C ET AL, "Kidney Androgen-regulated Protein Interacts with Cyclosphilin B and Reduces Cyclosporine A-mediated Toxicity in Proximal Tubule Cells.", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (2001), vol. 276, no. 31, pages 29410 - 29419, XP002486992 [Y] 1,4,6-10 * page 29418, column 3 * * page 29415, column 5 * * abstract * DOI: http://dx.doi.org/10.1074/jbc.M102916200
	International search	[Y]US5734016 (LEVENS DAVID L [US], et al);
		[Y]US5580760 (LEVENS DAVID L [US], et al);
		[YE]US2003220249 (HACKETT PERRY B [US], et al);
		[Y] - HATAKEYAMA S. ET AL., "Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases", JOURNAL OF BIOLOGICAL CHEMISTRY, (19970613), vol. 272, no. 24, pages 15085 - 15092, XP002977198 DOI: http://dx.doi.org/10.1074/jbc.272.24.15085
		[Y] - XU X-X. ET AL., "Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2", ONCOGENE, (1998), vol. 16, pages 1561 - 1569, XP002977199 DOI: http://dx.doi.org/10.1038/sj.onc.1201678

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p